ATC code H02

ATC codes

H Systemic hormonal preparations, excluding sex hormones and insulins

H01 Pituitary and hypothalamic hormones and analogues

H02 Corticosteroids for systemic use

H03 Thyroid therapy

ATC code H02 Corticosteroids for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup H02 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QH02...^[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H02A Corticosteroids for systemic use, plain

H02AA Mineralocorticoids

H02AA01 Aldosterone

H02AA02 Fludrocortisone

H02AA03 Desoxycortone

H02AB Glucocorticoids

H02AB01 Betamethasone

H02AB02 Dexamethasone

H02AB03 Fluocortolone

H02AB04 Methylprednisolone

H02AB05 Paramethasone

H02AB06 Prednisolone

H02AB07 Prednisone

H02AB08 Triamcinolone

H02AB09 Hydrocortisone

H02AB10 Cortisone

H02AB11 Prednylidene

H02AB12 Rimexolone

H02AB13 Deflazacort

H02AB14 Cloprednol

H02AB15 Meprednisone

H02AB17 Cortivazol

QH02AB30 Combinations of glucocorticoids

QH02AB56 Prednisolone, combinations

QH02AB57 Prednisone, combinations

QH02AB90 Flumetasone

H02B Corticosteroids for systemic use, combinations

H02BX Corticosteroids for systemic use, combinations

H02BX01 Methylprednisolone, combinations

QH02BX90 Dexamethasone, combinations

H02C Antiadrenal preparations

H02CA Anticorticosteroids

H02CA01 Trilostane

References

↑ "ATC/DDD Index 2016: code H02". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QH02". WHO Collaborating Centre for Drug Statistics Methodology.

Mineralocorticoids and antimineralocorticoids (H02)

Mineralocorticoids	11-Deoxycorticosterone (desoxycortone) 11-Deoxycortisol (cortodoxone) Aldosterone Corticosterone Cortisol (hydrocortisone) Desoxycortone acetate Desoxycortone enanthate Fludrocortisone Fludrocortisone acetate

Antimineralocorticoids	Amlodipine Benidipine Canrenoate potassium (potassium canrenoate) Canrenoic acid Canrenone Drospirenone Eplerenone Felodipine Finerenone Gestodene Nifedipine Nimodipine Nitrendipine Progesterone Spironolactone

Synthesis modifiers	Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Trilostane

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the Monday, February 25, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.